152 related articles for article (PubMed ID: 14612493)
1. Telomere dysfunction results in enhanced organismal sensitivity to the alkylating agent N-methyl-N-nitrosourea.
González-Suárez E; Goytisolo FA; Flores JM; Blasco MA
Cancer Res; 2003 Nov; 63(21):7047-50. PubMed ID: 14612493
[TBL] [Abstract][Full Text] [Related]
2. Decreased B16F10 melanoma growth and impaired vascularization in telomerase-deficient mice with critically short telomeres.
Franco S; Segura I; Riese HH; Blasco MA
Cancer Res; 2002 Jan; 62(2):552-9. PubMed ID: 11809709
[TBL] [Abstract][Full Text] [Related]
3. Studies evaluating the utility of N-methyl-N-nitrosourea as a positive control in carcinogenicity studies in the p53+/- mouse.
Hoivik DJ; Allen JS; Wall HG; Nold JB; Miller RT; Santostefano MJ
Int J Toxicol; 2005; 24(5):349-56. PubMed ID: 16257854
[TBL] [Abstract][Full Text] [Related]
4. Absence of telomerase and shortened telomeres have minimal effects on skin and pancreatic carcinogenesis elicited by viral oncogenes.
Argilla D; Chin K; Singh M; Hodgson JG; Bosenberg M; de Solórzano CO; Lockett S; DePinho RA; Gray J; Hanahan D
Cancer Cell; 2004 Oct; 6(4):373-85. PubMed ID: 15488760
[TBL] [Abstract][Full Text] [Related]
5. Disease states associated with telomerase deficiency appear earlier in mice with short telomeres.
Herrera E; Samper E; Martín-Caballero J; Flores JM; Lee HW; Blasco MA
EMBO J; 1999 Jun; 18(11):2950-60. PubMed ID: 10357808
[TBL] [Abstract][Full Text] [Related]
6. Dysfunctional telomeres promote genomic instability and metastasis in the absence of telomerase activity in oncogene induced mammary cancer.
Bojovic B; Crowe DL
Mol Carcinog; 2013 Feb; 52(2):103-17. PubMed ID: 22086874
[TBL] [Abstract][Full Text] [Related]
7. Review: Animal models of N-Methyl-N-nitrosourea-induced mammary cancer and retinal degeneration with special emphasis on therapeutic trials.
Tsubura A; Lai YC; Miki H; Sasaki T; Uehara N; Yuri T; Yoshizawa K
In Vivo; 2011; 25(1):11-22. PubMed ID: 21282729
[TBL] [Abstract][Full Text] [Related]
8. Modulation of N-methyl-N-nitrosourea-induced crypt restricted metallothionein immunopositivity in mouse colon by a non-genotoxic diet-related chemical.
Donnelly ET; Bardwell H; Thomas GA; Williams ED; Hoper M; Crowe P; McCluggage WG; Stevenson M; Phillips DH; Hewer A; Osborne MR; Campbell FC
Carcinogenesis; 2004 May; 25(5):847-55. PubMed ID: 14729593
[TBL] [Abstract][Full Text] [Related]
9. Overexpression of human O6-alkylguanine DNA alkyltransferase (AGT) prevents MNU induced lymphomas in heterozygous p53 deficient mice.
Reese JS; Allay E; Gerson SL
Oncogene; 2001 Aug; 20(38):5258-63. PubMed ID: 11536039
[TBL] [Abstract][Full Text] [Related]
10. Telomere dysfunction induces environmental alterations limiting hematopoietic stem cell function and engraftment.
Ju Z; Jiang H; Jaworski M; Rathinam C; Gompf A; Klein C; Trumpp A; Rudolph KL
Nat Med; 2007 Jun; 13(6):742-7. PubMed ID: 17486088
[TBL] [Abstract][Full Text] [Related]
11. Cooperative interactions of p53 mutation, telomere dysfunction, and chronic liver damage in hepatocellular carcinoma progression.
Farazi PA; Glickman J; Horner J; Depinho RA
Cancer Res; 2006 May; 66(9):4766-73. PubMed ID: 16651430
[TBL] [Abstract][Full Text] [Related]
12. Telomerase deficiency and telomere dysfunction inhibit mammary tumors induced by polyomavirus middle T oncogene.
Jaskelioff M; Song W; Xia J; Liu C; Kramer J; Koido S; Gendler SJ; Calderwood SK; Gong J
Oncogene; 2009 Dec; 28(48):4225-36. PubMed ID: 19734944
[TBL] [Abstract][Full Text] [Related]
13. DNA copy number alterations and expression of relevant genes in mouse thymic lymphomas induced by gamma-irradiation and N-methyl-N-nitrosourea.
Kang HM; Jang JJ; Langford C; Shin SH; Park SY; Chung YJ
Cancer Genet Cytogenet; 2006 Apr; 166(1):27-35. PubMed ID: 16616109
[TBL] [Abstract][Full Text] [Related]
14. Thymomas induced by simple alkylating agents in C57BL/Cbi mice: kinetics of the dose response.
Frei JV; Lawley PD
J Natl Cancer Inst; 1980 Apr; 64(4):845-56. PubMed ID: 6928996
[TBL] [Abstract][Full Text] [Related]
15. Telomere length regulates the epigenetic status of mammalian telomeres and subtelomeres.
Benetti R; García-Cao M; Blasco MA
Nat Genet; 2007 Feb; 39(2):243-50. PubMed ID: 17237781
[TBL] [Abstract][Full Text] [Related]
16. Deficient mismatch repair improves organismal fitness and survival of mice with dysfunctional telomeres.
Siegl-Cachedenier I; Muñoz P; Flores JM; Klatt P; Blasco MA
Genes Dev; 2007 Sep; 21(17):2234-47. PubMed ID: 17785530
[TBL] [Abstract][Full Text] [Related]
17. Genetic analysis of myc and telomerase interactions in vivo.
Flores I; Evan G; Blasco MA
Mol Cell Biol; 2006 Aug; 26(16):6130-8. PubMed ID: 16880523
[TBL] [Abstract][Full Text] [Related]
18. Short telomeres, even in the presence of telomerase, limit tissue renewal capacity.
Hao LY; Armanios M; Strong MA; Karim B; Feldser DM; Huso D; Greider CW
Cell; 2005 Dec; 123(6):1121-31. PubMed ID: 16360040
[TBL] [Abstract][Full Text] [Related]
19. Telomerase deletion limits progression of p53-mutant hepatocellular carcinoma with short telomeres in chronic liver disease.
Lechel A; Holstege H; Begus Y; Schienke A; Kamino K; Lehmann U; Kubicka S; Schirmacher P; Jonkers J; Rudolph KL
Gastroenterology; 2007 Apr; 132(4):1465-75. PubMed ID: 17433324
[TBL] [Abstract][Full Text] [Related]
20. Autoimmune haemolytic disease in mice after exposure to a methylating carcinogen.
Harris G; Lawley PD; Asbery LJ; Chandler PM; Jones MG
Immunology; 1983 Jul; 49(3):439-49. PubMed ID: 6862520
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
